Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Why I’m accumulating

<< Previous

Bullboard Posts

Next >>

Comment by Actuarialon Feb 19, 2021 8:05am

140 Views

Post# 32607328

RE:Why I’m accumulating

So true. While ATE running up from $3.5 to $6 is a leap, it is still far from its full potential - $50? $100? The sky is the limit. GLTA longs!

bigmack1 wrote:
This next point was made by someone else earlier and it's all we need to think about (IMHO). (Canaccord Upraded the target price to $16.50)........

I for one, will not be overthinking this pure and wonderful play. I happily added to my juicy position yesterday and will continue to do so with any significant pullbacks. I won't be shaken in the slightest in my conviction.

It's also nice to know that the company has cash in the bank.

This my friends, is a pharmaceutical GOLD MINE:)